Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pepgen Inc (PEPG)

Pepgen Inc (PEPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 118,323
  • Shares Outstanding, K 32,596
  • Annual Sales, $ 0 K
  • Annual Income, $ -78,630 K
  • EBIT $ -94 M
  • EBITDA $ -94 M
  • 60-Month Beta 1.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.97

Options Overview Details

View History
  • Implied Volatility 711.35% ( +122.93%)
  • Historical Volatility 98.35%
  • IV Percentile 86%
  • IV Rank 100.00%
  • IV High 711.35% on 12/20/24
  • IV Low 331.03% on 11/27/24
  • Put/Call Vol Ratio 0.20
  • Today's Volume 6
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 12.22
  • Today's Open Interest 119
  • Open Int (30-Day) 30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.81
  • Number of Estimates 5
  • High Estimate -0.62
  • Low Estimate -1.05
  • Prior Year -0.82
  • Growth Rate Est. (year over year) +1.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.90 +25.17%
on 12/16/24
6.85 -47.01%
on 12/03/24
-0.77 (-17.50%)
since 11/20/24
3-Month
2.90 +25.17%
on 12/16/24
9.94 -63.46%
on 10/08/24
-5.57 (-60.54%)
since 09/20/24
52-Week
2.90 +25.17%
on 12/16/24
19.30 -81.19%
on 07/29/24
-2.87 (-44.15%)
since 12/20/23

Most Recent Stories

More News
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy

SRPT : 118.97 (-0.42%)
PEPG : 3.63 (-11.25%)
CAPR : 13.07 (+1.32%)
PepGen (NASDAQ: PEPG) Shares Phase 1 Clinical Trial Results of PGN-EDO51 Showing Positive Data in Treating Duchenne Muscular Dystrophy

PepGen, Inc. (NASDAQ: PEPG) is engaged as a clinical-stage biotechnology company, which is focused on the research and development of

PEPG : 3.63 (-11.25%)
PepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments

BOSTON, June 16, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide...

PEPG : 3.63 (-11.25%)
It’s Time To Nibble On These Two Recent IPOs 

It’s hard to know what to buy and what to sell with market conditions the way they are but it looks like a good time to start nibbling on these two recent IPOs. Bausch + Lomb (NYSE: BLCO) and PepGen...

BLCO : 18.00 (+0.28%)
PEPG : 3.63 (-11.25%)

Business Summary

PepGen Inc. is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen Inc. is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 4.60
2nd Resistance Point 4.40
1st Resistance Point 4.01
Last Price 3.63
1st Support Level 3.42
2nd Support Level 3.22
3rd Support Level 2.83

See More

52-Week High 19.30
Fibonacci 61.8% 13.03
Fibonacci 50% 11.10
Fibonacci 38.2% 9.16
Last Price 3.63
52-Week Low 2.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar